|
Volumn 47, Issue 4, 2000, Pages 224-
|
AIDS and Africa.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIFUNGAL AGENT;
FLUCONAZOLE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADOLESCENT;
ADULT;
AFRICA;
ARTICLE;
CRYPTOCOCCAL MENINGITIS;
DISEASE TRANSMISSION;
DRUG EFFECT;
ECONOMICS;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
IMMUNOLOGY;
MALE;
MIDDLE AGED;
PATHOGENICITY;
STANDARD;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ADOLESCENT;
ADULT;
AFRICA;
AIDS VACCINES;
ANTI-HIV AGENTS;
ANTIFUNGAL AGENTS;
DISEASE TRANSMISSION, VERTICAL;
FEMALE;
FLUCONAZOLE;
HIV;
HUMANS;
MALE;
MENINGITIS, CRYPTOCOCCAL;
MIDDLE AGED;
|
EID: 0034279527
PISSN: 00063347
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|